What We’re Building: A Mechanism-First Platform for Neuropsychiatry

Written By Hannah Newsome

1) The gap we’re targeting

  • Psychiatry has excellent clinicians, but the system is forced into trial-and-error because it lacks scalable biological measurement.

  • Oncology progressed by building an ecosystem around molecular profiling, stratified trials, and companion diagnostics. Neuropsychiatry hasn’t yet had its equivalent.

2) Our core idea

  • We treat neuropsychiatric syndromes as overlapping biological states (e.g., immune activation, synaptic plasticity disruption, stress circuitry dysregulation, metabolic dysfunction, substance-induced neuroadaptation).

  • Our platform is designed to map each person to a biological profile that can guide research hypotheses and treatment selection in the future.

Hannah Newsome
Next

What is Personalized, Precision Medicine?